News
Burrill & Company Leads $12.9 Million Series E Round In WhiteGlove Health April 16, 2012 | Press Release
Burrill & Company Leads $16.5 Million Round in WaveTec Vision to Commercialize Its Cataract Surgery Breakthrough April 16, 2012 | Press Release
Burrill & Company Leads ADMA Biologics’ $17.5 Million Private Placement April 15, 2012 | Press Release
See all NewsInternational

Yuko Amizaki
Business AnalystMalaysia
Yuko Amizaki joined Burrill & Company as Business Analyst in 2011. Yuko provides support for the decision making processes associated specifically with biogreentech and the Malaysian Life Sciences Capital Fund investments, and more generally in the life sciences. Yuko recently graduated from MIT Sloan School of Management with an MBA. She worked in corporate planning at Regimmune, a drug development biotech in Mountain View, CA. Previously, she was a consultant at Booz and Company in Tokyo, Japan. She holds a master of science in biology and bachelor of agriculture in applied life science.
